CBI USA & DGP Amend Exicure Stake Filing
Ticker: XCUR · Form: SC 13D/A · Filed: Aug 5, 2024 · CIK: 1698530
| Field | Detail |
|---|---|
| Company | Exicure, Inc. (XCUR) |
| Form Type | SC 13D/A |
| Filed Date | Aug 5, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, sec-filing, schedule-13d
Related Tickers: EXCR
TL;DR
CBI USA & DGP filed 13D/A amendment 13 for EXICURE, INC. - ownership change.
AI Summary
CBI USA, Inc. and DGP Co., Ltd. filed an amendment (No. 13) to their Schedule 13D on August 5, 2024, regarding their holdings in Exicure, Inc. The filing indicates a change in the reporting persons' beneficial ownership of Exicure's common stock. Kyungwon Oh is listed as the CEO of CBI USA, Inc. and DGP Co., Ltd.
Why It Matters
This amendment to a Schedule 13D filing signals a potential shift in significant ownership or control of Exicure, Inc., which could impact its stock price and strategic direction.
Risk Assessment
Risk Level: medium — Schedule 13D filings, especially amendments, often indicate significant changes in beneficial ownership which can lead to increased stock volatility.
Key Players & Entities
- CBI USA, Inc. (company) — Filing entity
- DGP Co., Ltd. (company) — Filing entity
- Exicure, Inc. (company) — Subject company
- Kyungwon Oh (person) — CEO of CBI USA, Inc. and DGP Co., Ltd.
- Jonathan Park (person) — Contact person at Baker & Hostetler LLP
FAQ
What specific change in beneficial ownership is reported in this amendment?
The filing is an amendment (No. 13) to Schedule 13D, indicating a change in the reporting persons' beneficial ownership of Exicure, Inc. common stock, but the exact nature and extent of the change are detailed within the full document, not summarized here.
Who are the primary entities filing this amendment?
CBI USA, Inc. and DGP Co., Ltd. are the primary entities filing this amendment.
What is the subject company of this filing?
The subject company is Exicure, Inc.
When was this amendment filed?
This amendment was filed on August 5, 2024.
Who is identified as the CEO of the filing entities?
Kyungwon Oh is identified as the Chief Executive Officer of CBI USA, Inc. and DGP Co., Ltd.
Filing Stats: 1,033 words · 4 min read · ~3 pages · Grade level 6.9 · Accepted 2024-08-05 18:22:26
Key Financial Figures
- $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti
Filing Documents
- d845592dsc13da.htm (SC 13D/A) — 42KB
- d845592dex991.htm (EX-99.1) — 10KB
- d845592dex992.htm (EX-99.2) — 8KB
- 0001193125-24-194100.txt ( ) — 61KB
is supplemented as follows
Item 6 is supplemented as follows: On July 31, 2024, DGP and OverdigmK entered into an amendment of the DGP Sale Agreement, as amended, a translated copy of which is attached hereto as an Exhibit, pursuant to which the closing date for the balance of the DGP Sale was extended to September 30, 2024. On the same day, DGP and OverdigmK entered into an assignment and waiver agreement, a translated copy of which is attached hereto as an Exhibit, pursuant to which the parties agreed that the DGP Sale Agreement may be terminated or assigned to a third party upon DGPs request. Item7. Material to be Filed as Exhibits.
is supplemented by adding the following exhibits
Item 7 is supplemented by adding the following exhibits: Exhibit No. Name 1. Second Amendment to Stock Purchase Agreement between DGP and OverdigmK* 2. Assignment and Waiver Agreement* * English language provisions are a translation.
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned hereby certifies that the information set forth in this statement is true, complete and correct. Date: August 5, 2024 CBI USA, INC. By: /s/ Kyungwon Oh Name: Kyungwon Oh Title: Chief Executive Officer DGP Co., Ltd. By: /s/ Kyungwon Oh Name: Kyungwon Oh Title: Chief Executive Officer